Piloting Novel Interventional Strategies to Improve Nicotine Pouches as a Substitute for Smoking
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Amanda Palmer, PhD · PRINCIPAL_INVESTIGATOR · Medical University of South Carolina
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- FeasibilityDays 1-56
Feasibility endpoints include 1) the proportion of eligible subjects who subsequently enroll; 2) the proportion of enrolled subjects who complete the Day 28 and Day 56 assessments; and 3) the proportion of enrolled subjects who complete ≥80% of their daily surveys during the switching period.
- AcceptabilityDay 28
Acceptability endpoints will be measured by the Acceptability of Intervention Measure (AIM). This measure includes 4 items rated on scale of 1 to 5. Scores are created by averaging responses, with values ranging from 1 to 5. Higher values indicate higher acceptability.